glucose, (beta-d)-isomer has been researched along with Arthropathies in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Bao, B; Gao, T; Lin, J; Wei, H; Zheng, X; Zhu, H | 1 |
Cunha, FQ; Cunha, TM; Ferreira, SH; Guerrero, AT; Pinto, LG; Verri, WA; Vieira, SM; Zaperlon, AC; Zarpelon, AC | 1 |
Zvaifler, NJ | 1 |
3 other study(ies) available for glucose, (beta-d)-isomer and Arthropathies
Article | Year |
---|---|
Does Training Innate Immunity Confer Broad-spectrum Protection Against Bone and Joint Infection in a Mouse Model?
Topics: Animals; Bone Diseases, Infectious; Disease Models, Animal; Female; Immunity, Innate; Joint Diseases; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Zymosan | 2020 |
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia.
Topics: Animals; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; Imidazoles; Immune System Diseases; Inflammation; Joint Diseases; Leukocyte Disorders; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Neutrophils; Platelet Activating Factor; Platelet Membrane Glycoproteins; Prostaglandins; Receptors, G-Protein-Coupled; Time Factors; Zymosan | 2013 |
Breakdown products of C 3 in human synovial fluids.
Topics: Animals; Arthritis, Infectious; Arthritis, Juvenile; Arthritis, Reactive; Arthritis, Rheumatoid; Complement Fixation Tests; Complement System Proteins; gamma-Globulins; Humans; Immune Sera; Immunoelectrophoresis; Joint Diseases; Rabbits; Rheumatoid Factor; Spondylitis, Ankylosing; Synovial Fluid; Synovitis; Zymosan | 1969 |